U.S. drug regulators influenced the decision not to send an alert on heart inflammation cases that were appearing after COVID-19 vaccination, according to emails obtained through the Freedom of Information Act.
The U.S. Centers for Disease Control and Prevention was preparing to issue an alert about postvaccination myocarditis, or heart inflammation, through its Health Alert Network in May 2021.
The FDA did not deny influencing the decision not to send the alert.
"The FDA continues to work collaboratively with the CDC to monitor for known safety risks related to vaccines and determine how best to ensure any relevant safety information is conveyed to the public, health care providers and clinicians," a spokesperson told The Epoch Times in an email.
A CDC spokesperson declined to say why the CDC decided not to send an alert.
Dr. Rachel Levine, the administration's assistant secretary for health, and Dawn O'Connell, the administration's assistant secretary for preparedness and response, were going to be sent a draft of the alert after Dr. Walensky reviewed it, according to the emails.
Still, the AAP experts conveyed that "Significant risks that can be associated with adolescent myocarditis" and that youth with the heart inflammation should be placed under exercise limitations for at least three months, according to the emails.
No comments:
Post a Comment